113. 筋ジストロフィー
[臨床試験数:567,薬物数:442(DrugBank:93),標的遺伝子数:55,標的パスウェイ数:151

Searched query = "Muscular dystrophy", "Dystrophinopathies", "Myotilinopathy", "Laminopathy", "Caveolinopathy", "LGMD1C", "Desminopathy", "Sarcoglycanopathy", "α-dystroglycanopathy", "FCMD", "Walker-Warburg syndrome", "Muscle-eye-brain disease", "Myotonic dystrophy", "Integrin α7 deficient CMD", "Rigid spine syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03067831
(ClinicalTrials.gov)
September 201525/2/2017Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular DystrophySafety and Efficacy of Purified Autologous Bone Marrow-Derived Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy.Duchenne Muscular DystrophyBiological: Stem CellsStem Cells ArabiaNULLRecruiting4 Years25 YearsAll20Phase 1;Phase 2Jordan
2NCT02235844
(ClinicalTrials.gov)
September 20148/9/2014Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)Allogeneic Transplantation of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)Duchenne's Muscular DystrophyBiological: Umbilical Cord Mesenchymal Stem CellsAllergy and Asthma Consultants, Wichita, KansasAidan Foundation;Neil H. Riordan PhDCompleted28 Years31 YearsMale1Phase 1United States
3NCT02285673
(ClinicalTrials.gov)
November 20135/11/2014Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular DystrophyEfficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy: Phase 1/2 StudyDuchenne Muscular DystrophyBiological: Umbilical Cord Mesenchymal Stem CellAcibadem UniversityNULLRecruiting7 Years20 YearsMale10Phase 1;Phase 2Turkey
4NCT01610440
(ClinicalTrials.gov)
October 201121/5/2012Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular DystrophyPhase I/II Study of Stem Cell Therapy in Patients With Duchenne Muscular DystrophyDuchenne Muscular DystrophyBiological: human umbilical cord mesenchymal stem cellsShenzhen Beike Bio-Technology Co., Ltd.The Second Affiliated Hospital of Kunming Medical UniversityRecruiting5 Years12 YearsBoth15Phase 1;Phase 2China